Improved, integrated care for older patients with complex medical needs could avert some modifiable causes of readmission
The incidence of peripheral artery disease (PAD) is rising around the world as populations age and the prevalence of diabetes, obesity, and cardiovascular disease increase.1 The clinical manifestations of lower limb PAD range from asymptomatic atherosclerosis and exertional pain caused by intermittent claudication, to chronic limb‐threatening ischaemia with rest pain, ulceration, and necrosis. Long term survival is poorer for patients with PAD than for people with many common cancers,1 and quality of life and patient‐reported outcomes are impaired.2 A recently published analysis of Global Burden of Disease Study data found that lower limb amputation rates were higher in Australia than in eighteen other high income countries, highlighting the need to improve outcomes for people with PAD.3
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: 1329–1340.
- 2. Abaraogu UO, Ezenwankwo EF, Dall PM, Seenan CA. Living a burdensome and demanding life: a qualitative systematic review of the patients experiences of peripheral arterial disease. PLoS One 2018; 13: e0207456.
- 3. Hughes W, Goodall R, Salciccioli JD, et al. Trends in lower extremity amputation incidence in European Union 15+ countries 1990–2017. Eur J Vasc Endovasc Surg 2020; 60: 602–612.
- 4. Woelk V, Speck P, Kaambwa B, et al. Incidence and causes of early unplanned readmission after hospitalisation with peripheral arterial disease in Australia and New Zealand. Med J Aust 2022; 216: 80–86.
- 5. Smith SL, Matthews EO, Moxon JV, Golledge J. A systematic review and meta‐analysis of risk factors for and incidence of 30‐day readmission after revascularization for peripheral artery disease. J Vasc Surg 2019; 70: 996–1006.e7.
- 6. Thillainadesan J, Aitken SJ, Monaro SR, et al. Geriatric comanagement of older vascular surgery inpatients reduces hospital‐acquired geriatric syndromes. J Am Med Dir Assoc 2021; https://doi.org/10.1016/j.jamda.2021.09.037 [online ahead of print].
- 7. Thillainadesan J, Yumol MF, Hilmer S, et al. Interventions to improve clinical outcomes in older adults admitted to a surgical service: a systematic review and meta‐analysis. J Am Med Dir Assoc 2020; 21: 1833–1843.
- 8. Vogel TR, Kruse RL. Risk factors for readmission after lower extremity procedures for peripheral artery disease. J Vasc Surg 2013; 58: 90–97.e1‐4.
- 9. Anand SS, Caron F, Eikelboom JW, et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 2018; 71: 2306–2315.
- 10. Paige E, Doyle K, Jorm L, et al. A versatile big data health system for Australia: driving improvements in cardiovascular health. Heart Lung Circ 2021; 30: 1467–1476.
- 11. Medicare Benefits Schedule Review Taskforce. Vascular Clinical Committee report. Updated 28 May 2021. https://www.health.gov.au/resources/publications/taskforce‐findings‐vascular‐clinical‐committee‐report (viewed Dec 2021).
No relevant disclosures.